why choose us

First received: March 20, 2023

Clinical Trial: Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Lymphoblastic Leukemia

Study Type: OBSERVATIONAL


Official Title: Anti-mullerian Hormone in Pediatric Patients Treated for Acute Lymphoblastic Leukemia

Brief Summary: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, with current survival rates exceeding 90%.As cure rates improve, increasing attention is focused on survivor quality of life, including fertility.It is generally accepted that cancer treatments in childhood may interfere with gonadal function, reducing the pool of primordial follicles and consequently causing premature menopause in women.Anti-Mullerian hormone (AMH) levels is a valuable quantitative indicator of ovarian reserve, being…

Read more